ATR-12

N/A

Report date: 2024/08/21 15:09:35

Base Information

Drug NameATR-12
Drug Alias NameATR-12AZT-02ATR-02ATR12-351
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionBacteria replacementsSerine protease inhibitor Kazal-type 5 modulators
TargetsSerine protease inhibitor Kazal-type 5
Therapy Area/IndicationsIchthyosiform Erythroderma, CongenitalNetherton Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAzitra Inc
China Registration ClassN/A

Develop Information

Active CompaniesAzitra Inc
Inactive CompaniesN/A
Active IndicationsIchthyosiform Erythroderma, CongenitalNetherton Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A